| A palette of cytokines to measure anti-tumor efficacy of T cell-based therapeutics P Ramesh, R Shivde, D Jaishankar, D Saleiro, IC Le Poole Cancers 13 (4), 821, 2021 | 28 | 2021 |
| Benign tumors in TSC are amenable to treatment by GD3 CAR T cells in mice A Thomas, S Sumughan, ER Dellacecca, RS Shivde, N Lancki, ... JCI insight 6 (22), 2021 | 9 | 2021 |
| Increased otoferlin expression in B cells is Associated with muscle weakness in untreated juvenile dermatomyositis: a pilot study A Bukhari, A Khojah, W Marin, A Khramtsov, G Khramtsova, C Costin, ... International journal of molecular sciences 24 (13), 10553, 2023 | 3 | 2023 |
| HSP70iQ435A to subdue autoimmunity and support anti-tumor responses D Jaishankar, C Cosgrove, P Ramesh, J Mahon, R Shivde, ... Cell Stress and Chaperones 26, 845-857, 2021 | 2 | 2021 |
| Arid1a-dependent canonical BAF complex suppresses inflammatory programs to drive efficient Germinal Center B cell responses A Abraham, D Samaniego-Castruita, I Han, P Ramesh, MT Tran, ... Nature Immunology, 1-14, 2024 | | 2024 |
| Loss of SWI/SNF Complex Subunit Arid1a in B Cells Promotes Inflammation and Perturbs Germinal Center B Cell Responses A Abraham, D Samaniego-Castruita, J Paladino, MT Tran, IG Han, ... Blood 142 (Supplement 1), 1400-1400, 2023 | | 2023 |
| Skin Infiltrate Composition as a Telling Measure of Responses to Checkpoint Inhibitors C Kosche, D Jaishankar, C Cosgrove, P Ramesh, S Hong, L Li, ... JID Innovations 3 (5), 100190, 2023 | | 2023 |
| A Palette of Cytokines to Measure Anti-Tumor Efficacy of T Cell-Based Therapeutics. Cancers 2021, 13, 821 P Ramesh, R Shivde, D Jaishankar, D Saleiro, IC Le Poole s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | | 2021 |
